Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
DIREVO Biotech AG
Download detailed PDF Members: DIREVO Biotech AG is the leading company in the screening-based directed evolution of genes and proteins. Our proprietary platform technologies combine efficient DNA variation methods for mutation and recombination of genes with ultra-high throughput screening technologies. This integrated DIREVO Process is fully automated and works in highly miniaturized formats with throughput rates of up to millions of isolated protein variants per day in most application-relevant assays. DIREVO has built up a dominant position in the screening-based directed evolution which is based on a strong IP position. The DIREVO Process is covered by more than 40 patent and license families. With its rapid and highly flexible screening-based directed evolution process, DIREVO has a broad access to several multi-billion dollar markets such as protein pharmaceuticals, industrial enzymes, chemical biocatalysts as well as proteins for the food and the agricultural sector. Within these markets, DIREVO is currently working on several product developments which offer high-value opportunities.
This page has been viewed 319 times since April 2007, the link to the organisation's website has been followed 50 times Search for more companies in Cologne This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for DIREVO Biotech AG | ||||||||||||||||||||||||||||||||||||||||||||||||
|